SCHEMBL4083431

SCHEMBL4083431

CCN(C(=O)ON=[N+]=[N-])[C@@H](C)CC1CCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1567518 0.87 NPY5R (0.31) —
SCHEMBL15049873 0.76 — —
SCHEMBL4079760 0.73 — —
SCHEMBL4972999 0.73 — —
SCHEMBL13567599 0.72 — —
SCHEMBL15049751 0.70 MGLL (0.30) —
SCHEMBL4071170 0.70 NPY5R (0.34) —
SCHEMBL15049847 0.70 PSEN1 (0.30) —
SCHEMBL3959489 0.70 NPY5R (0.34) —
SCHEMBL4974850 0.70 NPY5R (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074108-A1 RENIN INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2009-07-01 — — EP disclosed
WO-2008036247-A1 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-03-27 — — WO disclosed
Send feedback